Filtered By:
Condition: Pneumonia

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 13068 results found since Jan 2013.

Transmission and Profile of COVID-19 in Children in North Sumatera, Indonesia
CONCLUSION: A high number of children in North Sumatera were affected by COVID-19, and mortality was found to be higher in children with underlying diseases. Major clusters were found in places with prolonged and repeated activities in close contact, such as boarding schools and a refugee shelter.PMID:37543898 | DOI:10.34172/aim.2022.116
Source: Archives of Iranian Medicine - August 6, 2023 Category: Middle East Health Authors: Ayodhia Pitaloka Pasaribu Restuti Hidayani Saragih Fahmi Fahmi Syahril Pasaribu Source Type: research

Long-running ProMED email service for alerting world to disease outbreaks is in trouble
The first news about the COVID-19 pandemic came not from a government or a scientific publication, but in an email from a disease-alert system called ProMED . This fateful missive in December 2019 about a few cases of a mysterious pneumonia in Wuhan, China, is just one example of how physicians and public health experts around the world have used the 30-year-old, free service to share real-time information about local disease outbreaks with tens of thousands of subscribers. But ProMED is now on life support. Much of its work came to a screeching halt yesterday when 21 of its 38 paid editors and moderators went o...
Source: Science of Aging Knowledge Environment - August 4, 2023 Category: Geriatrics Source Type: research

Radiological assessment of immunotherapy effects and immune checkpoint-related pneumonitis for lung cancer
This article reviews the complications of immunotherapy in lung cancer and illustrates various radiologic patterns of ICI-pneumonitis. Additionally, it is tried to differentiate ICI-pneumonitis from other pulmonary pathologies common to lung cancer such as radiation pneumonitis, bacterial pneumonia and coronavirus disease of 2019 (COVID-19) infection in recent months. Maybe it is challenging to distinguish radiologically but clinical presentation may help.PMID:37525480 | DOI:10.1111/jcmm.17895
Source: Molecular Medicine - August 1, 2023 Category: Molecular Biology Authors: Qiongjie Hu Shaofang Wang Li Ma Ziyan Sun Zilin Liu Shuang Deng Jianlin Zhou Source Type: research

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Blood Cancer J. 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7.ABSTRACTBispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice. However, this new class of therapies is associated with a distinct adverse event (AE) profile that includes cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, as well as AEs leading to increased infection risk such as cytopenias and hypogammaglobulinemia, and infections themselves. As preliminary data with this clas...
Source: Herpes - August 1, 2023 Category: Infectious Diseases Authors: Noopur Raje Kenneth Anderson Hermann Einsele Yvonne Efebera Francesca Gay Sarah P Hammond Alexander M Lesokhin Sagar Lonial Heinz Ludwig Philippe Moreau Krina Patel Karthik Ramasamy Maria-Victoria Mateos Source Type: research

Radiological assessment of immunotherapy effects and immune checkpoint-related pneumonitis for lung cancer
This article reviews the complications of immunotherapy in lung cancer and illustrates various radiologic patterns of ICI-pneumonitis. Additionally, it is tried to differentiate ICI-pneumonitis from other pulmonary pathologies common to lung cancer such as radiation pneumonitis, bacterial pneumonia and coronavirus disease of 2019 (COVID-19) infection in recent months. Maybe it is challenging to distinguish radiologically but clinical presentation may help.PMID:37525480 | DOI:10.1111/jcmm.17895
Source: J Cell Mol Med - August 1, 2023 Category: Molecular Biology Authors: Qiongjie Hu Shaofang Wang Li Ma Ziyan Sun Zilin Liu Shuang Deng Jianlin Zhou Source Type: research

Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
ConclusionOur study suggests that measurements of PCT and CRP, alone and at a single time point, are not useful for ruling in or out bacterial coinfection in viral pneumonia by COVID-19.
Source: Intensive Care Medicine - July 28, 2023 Category: Intensive Care Source Type: research

Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - July 26, 2023 Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research

Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - July 26, 2023 Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research

Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - July 26, 2023 Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research

Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - July 26, 2023 Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research

Effects of hydroxychloroquine plus favipiravir treatment on the clinical course and biomarkers in hospitalized covid-19 patients with pneumonia
CONCLUSION: Although the combination of HCQ + FAV treatment was observed to be effective on CRP levels and fever response in patients with COVID-19 pneumonia, there was no difference in terms of hospital stay and discharge.PMID:37492367 | PMC:PMC10364115 | DOI:10.20471/acc.2022.61.03.05
Source: Acta Clinica Croatica - July 26, 2023 Category: General Medicine Authors: Leman Acun Delen Abdullah Gok Umut Sabri Kasapoglu Ozlem Cagasar Zarife Gok Nurcan Berber Serdar Derya Bora Tetik Source Type: research